Invention Grant
- Patent Title: Therapeutic inhibitory compounds
-
Application No.: US16382070Application Date: 2019-04-11
-
Publication No.: US10781200B2Publication Date: 2020-09-22
- Inventor: Andrew McDonald , Shawn Qian
- Applicant: Attune Pharmaceuticals, Inc.
- Applicant Address: US NY New York
- Assignee: ATTUNE PHARMACEUTICALS, INC.
- Current Assignee: ATTUNE PHARMACEUTICALS, INC.
- Current Assignee Address: US NY New York
- Agency: Wilson Sonsini Goodrich & Rosati
- Main IPC: C07D413/14
- IPC: C07D413/14 ; C07D401/14 ; C07D471/04 ; C07D487/04 ; A61K31/4245
Abstract:
Provided herein are heterocyclic derivative compounds and pharmaceutical compositions comprising said compounds that are useful for inhibiting plasma kallikrein. Furthermore, the subject compounds and compositions are useful for the treatment of diseases wherein the inhibition of plasma kallikrein inhibition has been implicated, such as angioedema and the like.
Public/Granted literature
- US20200239435A1 THERAPEUTIC INHIBITORY COMPOUNDS Public/Granted day:2020-07-30
Information query
